Company intelligence / Profile preview

BIOSYNEX

Illkirch-Graffenstaden, Grand Est, France

Ownership: Private
Employees: ~501
Development stage: Other

Overview

BIOSYNEX designs, manufactures, and markets rapid diagnostic solutions; its products are certified (ISO 9001:2015, ISO 13485:2016) and distributed in over 90 countries for preventive and personalized healthcare[1][2].

Therapeutic areas: Infectious DiseasesWomen's HealthOther
Modalities: DeviceDiagnostic kit
Industry: Protein Biomarker Diagnostics

Partnerships

Collaborates with renowned medical institutes for R&D and validation

Beyond the preview

Go deeper on BIOSYNEX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOSYNEX.

Explore the full profile